Cleared Traditional

K092181 - HEMOSIL ACUSTAR CARDIOLIPIN IGG, IGM AND IGG AND IGM CONTROLS (FDA 510(k) Clearance)

Mar 2010
Decision
233d
Days
Class 2
Risk

K092181 is an FDA 510(k) clearance for the HEMOSIL ACUSTAR CARDIOLIPIN IGG, IGM AND IGG AND IGM CONTROLS. This device is classified as a System, Test, Anticardiolipin Immunological (Class II - Special Controls, product code MID).

Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on March 11, 2010, 233 days after receiving the submission on July 21, 2009.

This device falls under the Immunology FDA review panel. Regulated under 21 CFR 866.5660.

Submission Details

510(k) Number K092181 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 21, 2009
Decision Date March 11, 2010
Days to Decision 233 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF

Device Classification

Product Code MID — System, Test, Anticardiolipin Immunological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.5660